These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33947268)

  • 21. Ethics of HIV cure research: an unfinished agenda.
    Dubé K; Kanazawa J; Taylor J; Dee L; Jones N; Roebuck C; Sylla L; Louella M; Kosmyna J; Kelly D; Clanton O; Palm D; Campbell DM; Onaiwu MG; Patel H; Ndukwe S; Henley L; Johnson MO; Saberi P; Brown B; Sauceda JA; Sugarman J
    BMC Med Ethics; 2021 Jun; 22(1):83. PubMed ID: 34193141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies.
    Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
    AIDS Res Ther; 2020 Nov; 17(1):65. PubMed ID: 33168019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure Research.
    Dubé K; Auerbach JD; Stirratt MJ; Gaist P
    J Int AIDS Soc; 2019 Oct; 22(10):e25404. PubMed ID: 31665568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partner protections in HIV cure-related trials involving analytical treatment interruption: Updated toolkit to mitigate HIV transmission risk.
    Dubé K; Villa TJ; Freshwater W; Mauk B; Rid A; Peluso MJ
    J Virus Erad; 2024 Sep; 10(3):100386. PubMed ID: 39364082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "I would really want to know that they had my back": Transgender women's perceptions of HIV cure-related research in the United States.
    Poteat T; Aqil A; Corbett D; Evans D; Dubé K
    PLoS One; 2020; 15(12):e0244490. PubMed ID: 33382760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States.
    Dubé K; Kanazawa J; Roebuck C; Johnson S; Carter WB; Dee L; Peterson B; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Shipley L; Bateman K; Howell BJ; Mounzer K; Tebas P; Montaner LJ
    HIV Res Clin Pract; 2022 Dec; 23(1):120-135. PubMed ID: 35348047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV/AIDS: a minority health issue.
    Cargill VA; Stone VE
    Med Clin North Am; 2005 Jul; 89(4):895-912. PubMed ID: 15925655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States.
    Dubé K; Taylor J; Sylla L; Evans D; Dee L; Burton A; Willenberg L; Rennie S; Skinner A; Tucker JD; Weiner BJ; Greene SB
    PLoS One; 2017; 12(1):e0170112. PubMed ID: 28122027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethical and practical considerations for interventional HIV cure-related research at the end-of-life: A qualitative study with key stakeholders in the United States.
    Kanazawa J; Gianella S; Concha-Garcia S; Taylor J; Kaytes A; Christensen C; Patel H; Ndukwe S; Rawlings S; Hendrickx S; Little S; Brown B; Smith D; Dubé K
    PLoS One; 2021; 16(7):e0254148. PubMed ID: 34270612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the Engagement of Racial and Ethnic Minorities in HIV Treatment and Vaccine Clinical Trials: A Scoping Review of Literature and Implications for Future Research.
    Bass SB; D'Avanzo P; Alhajji M; Ventriglia N; Trainor A; Maurer L; Eisenberg R; Martinez O
    AIDS Patient Care STDS; 2020 Sep; 34(9):399-416. PubMed ID: 32931317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recruitment of Underrepresented Minority Researchers into HIV Prevention Research: The HIV Prevention Trials Network Scholars Program.
    Vermund SH; Hamilton EL; Griffith SB; Jennings L; Dyer TV; Mayer K; Wheeler D
    AIDS Res Hum Retroviruses; 2018 Feb; 34(2):171-177. PubMed ID: 29145745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community Engagement Strategies for Underrepresented Racial and Ethnic Populations.
    Odedina FT; Wieland ML; Barbel-Johnson K; Crook JM
    Mayo Clin Proc; 2024 Jan; 99(1):159-171. PubMed ID: 38176825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Willingness of Racially Diverse Young Adults Living with HIV to Participate in HIV Cure Research: A Cross-Sectional Survey in the United States.
    Dubé K; Campbell CK; Eskaf S; Sauceda JA; Ndukwe S; Henley L; Persaud D; Deeks SG; Auerbach JD; Saberi P
    AIDS Res Hum Retroviruses; 2023 Aug; 39(8):381-399. PubMed ID: 36226414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection.
    van Paassen P; Dijkstra M; Peay HL; Rokx C; Verbon A; Reiss P; Prins JM; Henderson GE; Rennie S; Nieuwkerk PT; de Bree GJ
    J Virus Erad; 2022 Jun; 8(2):100072. PubMed ID: 35769632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short Communication: Population Representation in HIV Cure Research: A Review of Diversity Within HIV Cure Studies Based in the United States.
    Roberts C; Creamer E; Boone CA; Young AT; Magnus M
    AIDS Res Hum Retroviruses; 2022 Aug; 38(8):631-644. PubMed ID: 35018803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.
    Julg B; Dee L; Ananworanich J; Barouch DH; Bar K; Caskey M; Colby DJ; Dawson L; Dong KL; Dubé K; Eron J; Frater J; Gandhi RT; Geleziunas R; Goulder P; Hanna GJ; Jefferys R; Johnston R; Kuritzkes D; Li JZ; Likhitwonnawut U; van Lunzen J; Martinez-Picado J; Miller V; Montaner LJ; Nixon DF; Palm D; Pantaleo G; Peay H; Persaud D; Salzwedel J; Salzwedel K; Schacker T; Sheikh V; Søgaard OS; Spudich S; Stephenson K; Sugarman J; Taylor J; Tebas P; Tiemessen CT; Tressler R; Weiss CD; Zheng L; Robb ML; Michael NL; Mellors JW; Deeks SG; Walker BD
    Lancet HIV; 2019 Apr; 6(4):e259-e268. PubMed ID: 30885693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption.
    Peluso MJ; Dee L; Campbell D; Taylor J; Hoh R; Rutishauser RL; Sauceda J; Deeks SG; Dubé K
    J Virus Erad; 2020 Feb; 6(1):34-37. PubMed ID: 32175090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethical HIV research with transgender and non-binary communities in the United States.
    Klein A; Golub SA
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25971. PubMed ID: 36225134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical race theory as a tool for understanding poor engagement along the HIV care continuum among African American/Black and Hispanic persons living with HIV in the United States: a qualitative exploration.
    Freeman R; Gwadz MV; Silverman E; Kutnick A; Leonard NR; Ritchie AS; Reed J; Martinez BY
    Int J Equity Health; 2017 Mar; 16(1):54. PubMed ID: 28340589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Qualitative Community Assessment of Racial/Ethnic Sexual Gender Minority Young Adults: Principles for Strategies to Motivate Action(s) for Realistic Tasks (SMART Thinking) Addressing HIV/AIDS, Viral Hepatitis, Mental Health, and Substance Abuse.
    Jeremiah R; Taylor B; Castillo A; Garcia V
    Am J Mens Health; 2020; 14(5):1557988320966230. PubMed ID: 33084464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.